Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients-Reference-Cited by-同舟云学术

Levels of uninvolved immunoglobulins predict clinical status and progression-free survival for multiple myeloma patients

Published:2016-03-27 Issue:1 Volume:174 Page:81-87
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:Br J Haematol

Author:

Harutyunyan Nika M.¹,Vardanyan Suzie¹,Ghermezi Michael¹,Gottlieb Jillian¹,Berenson Ariana¹,Andreu-Vieyra Claudia²,Berenson James R.¹²³

Affiliation:

1. Institute for Myeloma & Bone Cancer Research; West Hollywood CA USA

2. Oncotherapeutics; West Hollywood CA USA

3. James R. Berenson, MD, Inc.; West Hollywood CA USA

Funder

The Binding Site

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bjh.14026/fullpdf

Reference21 articles.

1. Serum immunoglobulin heavy/light chain ratios are independent risk factors for predicting progression free survival in multiple myeloma;Avet-Loiseau;Haematologica,2010

2. Multiple myeloma outcome is associated with polyclonal immunoglobulin suppression of the same isotype as the tumor;Avet-Loiseau;Haematologica,2011

3. Assessment of monoclonal gammopathies by nephelometric measurement of individual immunoglobulin kappa/lambda ratios;Bradwell;Clinical Chemistry,2009

4. Prognostic utility of intact immunoglobulin Igκ/Igλ ratios in multiple myeloma patients;Bradwell;Leukemia,2013

5. Consensus recommendations for standard investigative workup: report of the International Myeloma Workshop Consensus Panel 3;Dimopoulos;Blood,2011

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recovery of uninvolved heavy/light chain pair immunoparesis in newly diagnosed transplant-eligible myeloma patients complements the prognostic value of minimal residual disease detection;Haematologica;2023-11-30

2. The significance of autologous hematopoietic stem cell transplantation on immunoglobulin reconstitution and prognosis in elderly patients with multiple myeloma;Hematology;2023-09-21

3. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part II: Methodological and clinical recommendations for the diagnosis and follow-up of monoclonal gammopathies;Clinical Chemistry and Laboratory Medicine (CCLM);2023-07-04

4. Laboratory and Clinical Settings of Heavy/Light Chain (HLC) Assays in the Management of Monoclonal Gammopathies and Multiple Myeloma;Journal of Personalized Medicine;2023-04-27

5. Multiple Myeloma With a Rare Presentation at Preserved Uninvolved Immunoglobulins;Cureus;2022-05-31